International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Tyrosine Kinase level and White Blood Cells Count in Untreated and Treated Chronic Myelogenous Leukemia Patients with BCR ABL gene

Delita Prihatni, Rachmat Sumantri, Rully Roesli, Nadjwa Zamalek Dalimonthe, Ida Parwati

Abstract: Background Molecularly, Chronic Myelogenus Leukemia (CML) is defined by the Philadelphia chromosome, t (9, 22) (q34, q11.2), which encodes the BCR-ABL1 fusion protein, that disturb the function of tyrosine kinase. Role of tyrosine kinase activity in the cell, include cell-cycle control, transcription process, and mitogenesis, or induction of cells mitosis. This properties generate the use of Tyrosine Kinase Inhibitor for CML treatment through inhibition of signal transduction. The aim of this study is to find out the correlation between Tyrosine Kinase level as a mediator of signal transduction with the white blood cells count in untreated and treated patients with CML. Subject and methods This study was held on JanuaryJuly 2014 in Clinical Pathology Laboratory of Dr Hasan Sadikin General Hospital Bandung, Indonesia. Subjects were divided into two groups untreated group and treated group after treatments for CML. Chronic Myelogenus Leukemia is diagnosed if BCR-ABL gene is detected using Reverse Transcriptase-Polymerase Chain Reaction technique. Complete blood count was done using Sysmex XT2100i, while tyrosine kinase level was analyzed by Enzyme-linked Immunosorbent Assay technique. Data were analyzed with Wilcoxon signed-rank test, and Spearmans analysis. Results Subject enrolled in this study were 57 CML patients, consist of 34 male and 23 female. We found a significant positive correlation between the number of white blood cell with Tyrosine Kinase level (r= 0.456, p

Keywords: CML, Tyrosine kinase, white blood cells count

How to Cite?: Delita Prihatni, Rachmat Sumantri, Rully Roesli, Nadjwa Zamalek Dalimonthe, Ida Parwati, "Tyrosine Kinase level and White Blood Cells Count in Untreated and Treated Chronic Myelogenous Leukemia Patients with BCR ABL gene", Volume 5 Issue 7, July 2016, International Journal of Science and Research (IJSR), Pages: 1312-1316, https://www.ijsr.net/getabstract.php?paperid=NOV152895, DOI: https://dx.doi.org/10.21275/NOV152895

Download Citation: APA | MLA | BibTeX | EndNote | RefMan

Share This Research

Help this article reach readers, researchers and professionals.

Share activity is measured for research-engagement analytics. Only verified, unique public shares can support award tie-breaking.

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.

Download Article PDF


Rate This Article!

Top

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.